Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002)

Objective This study aimed to find out whether side-specific pelvic lymphadenectomy can be omitted without compromising diagnostic efficacy according to “reflex frozen section” analysis of the uterus in case of sentinel lymph node (SLN) mapping failure. Methods Patients who underwent surgery for endometrial cancer with an SLN algorithm were stratified as low-risk or high-risk according to the uterine features on the final pathology reports. Two models for low-risk patients were defined to omit side-specific pelvic lymphadenectomy: strategy A included patients with endometrioid histology, grade 1–2, and <50% myometrial invasion irrespective of the tumor diameter; strategy B included all factors of strategy A with the addition of tumor diameter ≤2 cm. Theoretical side-specific pelvic lymphadenectomy rates were calculated for the two strategies, assuming side-specific pelvic lymphadenectomy was omitted if low-risk features were present on reflex uterine frozen examination, and compared with the standard National Comprehensive Cancer Network (NCCN) SLN algorithm. Results 372 endometrial cancer patients were analyzed. 230 patients (61.8%) had endometrioid grade 1 or 2 tumors with <50% myometrial invasion (strategy A), and in 123 (53.4%) of these patients the tumor diameter was ≤2 cm (strategy B); 8 (3.5%) of the 230 cases had lymphatic metastasis. None of them were detected by side-specific pelvic lymphadenectomy and metastases were limited to SLNs in 7 patients. At least one pelvic side was not mapped in 107 (28.8%) cases in the entire cohort, and all of these cases would require a side-specific pelvic lymphadenectomy based on the NCCN SLN algorithm. This rate could have been significantly decreased to 11.8% and 19.4% by applying reflex frozen section examination of the uterus using strategy A and strategy B, respectively. Conclusion Reflex frozen section examination of the uterus can be a feasible option to decide whether side-specific pelvic lymphadenectomy is necessary for all the patients who failed to map with an SLN algorithm. If low-risk factors are found on frozen section examination, side-specific pelvic lymphadenectomy can be omitted without compromising diagnostic efficacy for lymphatic spread.

[1]  A. Papadia,et al.  Oncological safety and perioperative morbidity in low-risk endometrial cancer with sentinel lymph-node dissection. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  J. Persson,et al.  Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. , 2019, European journal of cancer.

[3]  I. Alkatout,et al.  Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany , 2019, Archives of Gynecology and Obstetrics.

[4]  T. Staniscia,et al.  Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green , 2019, Gynecologic and Obstetric Investigation.

[5]  P. Escobar,et al.  Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. , 2018, The Lancet. Oncology.

[6]  Paula S Lee,et al.  Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer. , 2017, Gynecologic oncology.

[7]  T. Gungor,et al.  Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion? , 2017, International Journal of Gynecologic Cancer.

[8]  K. Pavlakis,et al.  Identifiable Risk Factors for Lymph Node Metastases in Grade 1 Endometrial Carcinoma , 2017, International Journal of Gynecologic Cancer.

[9]  A. Fader,et al.  Sentinel lymph node assessment in endometrial cancer: a systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.

[10]  G. Tulunay,et al.  Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue , 2017, International Journal of Gynecologic Cancer.

[11]  A. Ivanova,et al.  A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. , 2017, The Lancet. Oncology.

[12]  S. Temkin,et al.  Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer. , 2016, Gynecologic oncology.

[13]  J. Soper,et al.  Endometrial Cancer and the Role of Lymphadenectomy , 2016, Obstetrical and Gynecological Survey.

[14]  A. Weaver,et al.  Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. , 2016, Gynecologic oncology.

[15]  A. Fader,et al.  Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. , 2015, Gynecologic oncology.

[16]  M. Plante,et al.  Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. , 2015, Gynecologic oncology.

[17]  M. Goodheart,et al.  Intra-operative frozen section results reliably predict final pathology in endometrial cancer. , 2014, Gynecologic oncology.

[18]  J. Schorge,et al.  Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. , 2014, Gynecologic oncology.

[19]  G. Tulunay,et al.  Accuracy of frozen-section examination for myometrial invasion and grade in endometrial cancer. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[20]  A. Mariani,et al.  A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. , 2012, Gynecologic oncology.

[21]  R. Barakat,et al.  The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. , 2012, Gynecologic oncology.

[22]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[23]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[24]  D. Levine,et al.  The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology , 2007, International Journal of Gynecologic Cancer.

[25]  M. J. Webb,et al.  Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? , 2000, American journal of obstetrics and gynecology.

[26]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.